Jon Adkins is the COO and Co-founder of XenoTherapeutics where he aids in the strategic development of the company’s initiatives and future growth through partnerships and alliances. His primary focus is collaborating with both internal and external stakeholders to continuously drive results.


Jon has spent more than 15 years in medical device sales, sales management, marketing and consulting with top corporations including Smith & Nephew, Depuy Synthes, and Zimmer Biomet. In these roles, he has managed multiple lines of business involving implantable medical devices and biologics, including those used in orthopedic joint reconstruction, spine and trauma surgeries. He has learned both the business of translational medicine as well as its application to the operating room and is committed to catalyzing technologies that focus on reducing the cost of healthcare through innovation, collaboration and thought leadership.


Jon graduated from the University of Florida and completed his MBA with an emphasis in Healthcare Management, at Southern New Hampshire University.